Flex Manager
21219 interim professionals
21219 professionals

 Select

Find similar resumes

Unabhängiger Consultant

Unabhängiger Consultant

Work Experience

- Brand strategy and operational planning, advocacy relationship management, communication platforms.
- Established expertise and relationships in diabetes, neuroscience and cardiovascular.
- Life cycle strategies and loss of exclusivity protection.
- Establishing new disease management strategies with top tier advocates and guideline committees.
_________________________________________________________________________
AstraZeneca (06/2006 - 11/2010)
As a global biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialisation of innovative medicines for some oft he world’s most serious diseases.

Global Brand Manager, Cardiovascular Division, Manchester, UK (09/2008 – 11/2010)

Accountable for global brand strategy planning of a leading statin, thought leaders relationship management, budget, and communication platforms.
Portfolio: CRESTOR®

Accomplishments
• Aspirational challenger strategy for Crestor vs. Lipitor launched.
• Patent protection strategy development.
• Within the first month on the team delivered Brand Strategy Plan through intensive collaboration.
• Developed a strategy for future KOL management as a consequence of a major organizational change.

Senior Product Manager, Neuroscience, Vienna, Austria (06/2006 – 09/2008)

Responsible for marketing the CNS product portfolio and leadership management of the Seroquel® core brand team.
Portfolio: Seroquel®, Zomig®
Accomplishments
• Adapted and launched a new positioning and brand identity for Seroquel®.
• Breakthrough sales campaign with clear focused messaging driven by extensive insight research.
• Achieved market share leadership (value and volume) and number one position in the AZ portfolio within less than two years of taking brand responsibility.
• Increased Seroquel’s annual sales by 26,8% and its market share by 3,2% (Dec 07).
• Delivery of a post-patent strategy with the extended release formulation.
• Re-defined the Zomig® brand equity and the patient segmentation, thereby kick started a significant market share increase.


Servier (03/2004 - 05/2006)
Leading French independent pharmaceutical company with a product portfolio in Hypertension, Diabetes, Osteoporosis and Neuroscience.

Product Manager and Medical Advisor, Diabetes, Vienna, Austria (03/2004 – 05/2006)

Responsible for all marketing activities, P&L, budgets, and as well as scientific questions related to the product.
Portfolio: Diamicron® MR

Accomplishments
• Delivered a new brand plan approach for mid and long term lifecycle planning, which established the critical success factors necessary to drive all marketing and sales activities.
• Achieved sales growth of 60% within two years and an annual market share growth of 5%.
• Strong business relationships with all key opinion leaders in the field of diabetes lead to a competitive guideline position in diabetes protocols.





Red Bull (10/2003 – 02/2004)
World leader in Energy Drinks, with annual sales of approx. 4 billion cans in more than 160 countries.

Scientific & Regulatory Affairs Manager, Headquarters, Austria
Portfolio: Red Bull®, Carpe Diem®

Accomplishments
• Generated a discussion paper for establishing the role of energy drinks in the food and nutrition market.
• Delivered a new product licence file (NDA) into the FDA in record time for Red Bull to achieve market access ahead of competition.
• Lead exploitation of the Asian markets via new distribution channels and a major new market opportunity


Novo Nordisk (05/1998 - 09/2002)
World leader in diabetes care. Leading position in coagulation disorders, growth disorders and hormone replacement therapy.
Portfolio: Diabetes, Coagulation disorders, Growth disorders & Hormone Replacement

Regulatory Affairs & Quality Manager, Strategic Operations, based in Athens, Greece (07/2000 - 09/2002)
International Operations & Strategic Operations covered 158 countries in Asia, Africa, Latin America, Middle East and parts of Europe overlooking the development and growth of business in the Emerging Markets.

Accomplishments
• Accountable for internal and external regulatory process analysis and regulatory performance evaluation.
• Optimized regulatory processes in partnership with the business areas to improve the launch process.
• Positioned Reg. Affairs as a strategic function with global perspective at regional and corporate levels.
• Co-Chaired the International Operations Regulatory Affairs Board, ensuring appropriate interaction with stakeholders, leading to better practices and resolution of operational issues.
• Initiated the streamlining of the total portfolio.

Regional Office Central Eastern Europe & Latin America, based in Vienna, Austria (05/1998 - 07/2000)
The Regional Centre Vienna served the 56 countries in Central & Eastern Europe and Latin America.

Regulatory Affairs & Quality Manager: 11/1999 – 06/2000
Regulatory Affairs Executive: 05/1998 – 10/1999
Project Assignment, Headquarters, Denmark: 04/1999 – 05/1999
Accomplishments
• Mobilisation of a cross-functional task force to deal with EU-enlargement issues.
• Spearheaded the development of competencies within the region.
• Established a commercial mind set in the regulatory function to maximize the lifecycle opportunities.


Octapharma (11/1993 - 04/1998)
International company involved in the development, production and sale of high quality plasma derivative products.

Quality Control & Regulatory Affairs Specialist, Headquarters, Vienna, Austria
Portfolio: Plasma Derivatives

Accomplishments
• Developed a style of leadership that enabled effective decision-making and process optimisation.
• Team Leader for planning, implementation and evaluation of stability studies.
• Pharmacovigilance leadership in Austria.


Pharmacy “Apotheke zum römischen Kaiser”, Austria, Vienna (10/1992 - 10/1993)

European Approbation as Hospital & Community Pharmacist with honours



Education

Pharmacist, Degree: MSc. pharm. University of Vienna (1985-1992)
Thesis: Clinical relevance of the tumour markers TPS and Ferritin for carcinomas

License for manufacturing, wholesaling and distribution of pharmaceuticals (2008)

Lead Auditor Training Course
Qualifying examination for the Profession of Pharmacist with honours


Skills

Pharma Marketing
• Advocacy strategy and development
• Advisory boards, satellite/congress maximisation
• Disease area strategies, guidelines
• Communication programs
• Strategic brand planning (5y), operational planning (1y)
• Brand positioning and creative concept development
• Life cycle strategies and loss of exclusivity protection


Languages

German (native), English (fluent)
Italian & French (good understanding)
Russian & Greek (basic knowledge)


Other

Quality Control, Quality Assurance, REgulatory Affairs Expertise,

 Select

Candidate search for

interimmanagementPaste your project description here